See also this year's filing and all EDGAR filings for this company.
PDF Report 0001514946_2023_AXIM_BIOTECHNOLOGIES_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001514946, AXIM BIOTECHNOLOGIES INC.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 103,979 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 93,840 |
3 | remainder_Assets | 4,014,216 |
4 | LiabilitiesCurrent | 3,392,494 |
5 | LiabilitiesNoncurrent | 5,644,953 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 4,081,824 |
9 | ResearchAndDevelopmentExpense | 153,697 |
10 | remainder_Expenses | 426,126 |
11 | remainder_Revenues | 8,875 |
12 | remainder_NetIncome | 1,590,177 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 4,212,035 |
1 | Liabilities | 9,037,447 |
2 | Expenses | 4,661,647 |
3 | Revenues | 8,875 |
4 | StockholdersEquity | -4,825,412 |
5 | NetIncome | -3,062,595 |
6 | ComprehensiveNetIncome | -3,062,595 |
7 | BaseVar | 9,755,090 |
8 | EconomicCapitalRatio | -1.72 |